Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients.

ABSTRACT:

Background

COVID-19 pandemic is caused by coronavirus also known as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The viral infection continues to impact the globe with no vaccine to prevent the infection or highly effective therapeutics to treat the millions of infected people around the world. The disease starts as a respiratory infection, yet it may also be associated with a hypercoagulable state, severe inflammation owing to excessive cytokines production, and a potentially significant oxidative stress. The disease may progress to multiorgan failure and eventually death.

Objective

In this article, we summarize the potential of dipyridamole as an adjunct therapy for COVID-19.

Methods

We reviewed the literature describing the biological activities of

SUBMITTER: Aliter KF 

PROVIDER: S-EPMC7990686 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature